ORC Quote, Financials, Valuation and Earnings

Garden City Co. has a net margin of 76.51% compared to Orchid Island Capital, Inc.'s net margin of --. Orchid Island Capital, Inc.'s return on equity of 16.25% beat Garden City Co.'s return on equity of --.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling upside risk potential of 0.81%. On the other hand Garden City Co. has an analysts' consensus of -- which suggests that it could fall by --. Given that Orchid Island Capital, Inc. has higher upside potential than Garden City Co., analysts believe Orchid Island Capital, Inc. is more attractive than Garden City Co..

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison Garden City Co. has a beta of 0.414, suggesting its less volatile than the S&P 500 by 58.592%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 19.36%. Garden City Co. offers a yield of 1.11% to investors and pays a quarterly dividend of $40.00 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. Garden City Co. pays out -- of its earnings as a dividend.

Orchid Island Capital, Inc. quarterly revenues are $135.2M, which are larger than Garden City Co. quarterly revenues of --. Orchid Island Capital, Inc.'s net income of $103.4M is higher than Garden City Co.'s net income of --. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.17x while Garden City Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.34x versus -- for Garden City Co.. Usually stocks with elevated PS ratios are considered overvalued.

VG Life Sciences has a net margin of 76.51% compared to Orchid Island Capital, Inc.'s net margin of --. Orchid Island Capital, Inc.'s return on equity of 16.25% beat VG Life Sciences's return on equity of --.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling upside risk potential of 0.81%. On the other hand VG Life Sciences has an analysts' consensus of -- which suggests that it could fall by --. Given that Orchid Island Capital, Inc. has higher upside potential than VG Life Sciences, analysts believe Orchid Island Capital, Inc. is more attractive than VG Life Sciences.

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison VG Life Sciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 19.36%. VG Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. VG Life Sciences pays out -- of its earnings as a dividend.

Orchid Island Capital, Inc. quarterly revenues are $135.2M, which are larger than VG Life Sciences quarterly revenues of --. Orchid Island Capital, Inc.'s net income of $103.4M is higher than VG Life Sciences's net income of --. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.17x while VG Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.34x versus -- for VG Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Weyerhaeuser Co. has a net margin of 76.51% compared to Orchid Island Capital, Inc.'s net margin of 4.8%. Orchid Island Capital, Inc.'s return on equity of 16.25% beat Weyerhaeuser Co.'s return on equity of 3.39%.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling upside risk potential of 0.81%. On the other hand Weyerhaeuser Co. has an analysts' consensus of $31.64 which suggests that it could grow by 28.97%. Given that Weyerhaeuser Co. has higher upside potential than Orchid Island Capital, Inc., analysts believe Weyerhaeuser Co. is more attractive than Orchid Island Capital, Inc..

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison Weyerhaeuser Co. has a beta of 1.033, suggesting its more volatile than the S&P 500 by 3.253%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 19.36%. Weyerhaeuser Co. offers a yield of 3.42% to investors and pays a quarterly dividend of $0.21 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. Weyerhaeuser Co. pays out 187.58% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Orchid Island Capital, Inc. quarterly revenues are $135.2M, which are smaller than Weyerhaeuser Co. quarterly revenues of $1.5B. Orchid Island Capital, Inc.'s net income of $103.4M is higher than Weyerhaeuser Co.'s net income of $74M. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.17x while Weyerhaeuser Co.'s PE ratio is 54.79x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.34x versus 2.57x for Weyerhaeuser Co.. Usually stocks with elevated PS ratios are considered overvalued.